On December 13th, HUKUI Biotechnology Co., Ltd. (referred to as HUKUI) celebrated its 10th anniversary at the Courtyard by Marriott Taipei. The event brought together renowned enterprises, suppliers, and partners from various industries such as finance, manufacturing, and healthcare to commemorate this remarkable milestone.
HUKUI’s founder and chairman, John Hsuan, expressed in his opening speech that HUKUI will continue to expand its diversified medical technology services in response to international changes and strategic adjustments. Currently, HUKUI has successfully gathered outstanding talents from various fields such as optics, electronics, machinery, manufacturing, biomedicine, and software, demonstrating significant growth over the past decade. HUKUI’s CEO, Michael Kuo, sincerely thanked all partners and employees for their contribution over the past ten years and expressed HUKUI’s commitment to maintaining outstanding performance in the future. He also looked forward to facing more challenges with partners to create a brilliant future together.
The HUKUI 10th anniversary was held in a grand manner through a symposium and a banquet. The “AI Medical New Era ” symposium was held in the afternoon, inviting experts from the fields of healthcare, academic research, and finance to share insights on cutting-edge AI technology, medical technology, global medical materials industry trends, and experiences in startup investments.
In the speech at the 10th anniversary seminar, the president of the alumni association of National Yang Ming Chiao Tung University, Churchill Chen, reviewed the founding moment of HUKUI and emphasized the origin of the company name and its founding spirit. The word “HUKUI” is rooted in the meaning of “Helping One Another to Build a Prosperous Future”, which symbolizing mutual support within the team and jointly driving the prosperity and development of the business. The establishment of HUKUI aims to provide comprehensive solutions for design, manufacturing, and sales for emerging electronic medical device companies. Behind this original intention, it reveals a profound insight into the industry and a brave action to face the challenges, highlighting HUKUI’s leading position in promoting innovation in medical technology.
The evening banquet invited the guests from the industry, government, academia field, and research institution, including Sou-Shan Wu, Chairman of the Taipei Exchange, I-Jin Tsai, Deputy Executive Secretary of the National Development Fund and Executive Yuan, Kung-Liang Yeh, Director of Fubon Securities, and Tiao-Chun Wang , Chairman of the Taiwan Overseas Entrepreneurs Association. The banquet was warm and solemn. A video was arranged during the event to express gratitude for the past and to show the expectation for the future, leaving an unforgettable moment for the night.
HUKUI was founded in 2013 by Mr. John Hsuan, the Honorary Vice Chairman of UMC. It is one of the few domestic electronic medical device contract developing and manufacturing organization (CDMO) companies with an international perspective and the ability to provide customers with verification, production, and sales services. The company’s services include clinical trials, prototype development, OEM/ODM, and distribution and agency, aiming to create a one-stop service platform. Through its diverse business areas, HUKUI continuously promotes Taiwan’s excellence in the global medical technology field, injecting new vitality into the industry.
HUKUI is committed to promoting the application of medical image processing and artificial intelligence technology. Through innovative research and development and excellent technology. For more details, you can visit the HUKUI official website at https://www.hukuibio.com.
